Melanoma, Secondary cancers, Skin cancer
Results
Phase 3
This trial looked at a drug called pembrolizumab for melanoma that couldn’t be removed with surgery or that had spread to another part of the body. The trial was open to people with advanced melanoma who hadn’t had a drug called ipilimumab.
Recruitment start: 4 September 2013
Recruitment end: 31 January 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr James Larkin
Experimental Cancer Medicine Centre (ECMC)
Merck Sharp & Dohme Ltd
Last reviewed: 4 August 2016
CRUK internal database number: 11476
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
